Updated:
Regional Cancer Care Associates
Regional Cancer Care Associates is a community oncology network treating cancer and blood disorders in NJ, CT, MA, and DC-area locations.
Regional Cancer Care Associates
Regional Cancer Care Associates (RCCA) is a physician-led network of community oncology practices spanning New Jersey, Connecticut, Massachusetts, and the Washington, D.C., region. The group formed through the aggregation of independent practices to preserve local access to cancer and blood disorder treatment. Specific founding operators and the year of consolidation have not been publicly disclosed. The organization provides medical oncology, hematology, infusion therapy, and supportive care services across its outpatient centers. It treats a full range of cancers, including breast, lung, colorectal, prostate, and hematologic malignancies such as leukemia and lymphoma. RCCA participates in clinical trials and offers genetic counseling, integrating research into routine care. Its geographic reach covers at least four states and the District of Columbia. RCCA operates from multiple office locations including Princeton, Newark, Basel, Cambridge, and Parsippany. The network's professional headcount has not been disclosed. No philanthropic arm, operating company, or recent investment activity has been publicly linked to the entity. As a community oncology network, RCCA differentiates itself from hospital-based systems by offering coordinated care in lower-cost, suburban settings. Its structure allows patients to access advanced treatments and clinical research near their homes rather than traveling to academic medical centers. The governance model relies on physician leadership rather than private equity or large health system control.
General information
Firm type
Healthcare Services
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Princeton
Corporate office
Princeton, NJ, United States
Additional offices
Newark · Basel · Cambridge · Parsippany
Sector focus
Frequently asked questions
What types of cancer and blood disorders does RCCA treat?
RCCA treats a broad range of cancers including breast, lung, colorectal, prostate, and hematologic malignancies such as leukemia and lymphoma. It also manages non-cancer blood disorders. Care is delivered through medical oncology, hematology, infusion therapy, and supportive services across its centers.
Where are Regional Cancer Care Associates' treatment centers located?
RCCA has treatment centers in New Jersey (Princeton, Newark, Parsippany), Connecticut, Massachusetts (Cambridge), and the Washington, D.C., area. The network operates outpatient facilities designed to bring community-based care close to patients' homes.
Does RCCA participate in clinical trials?
Yes, RCCA engages in clinical trials and offers genetic counseling as part of its services. This allows patients to access investigational therapies and precision medicine approaches without traveling to large academic centers.
What is the ownership structure of RCCA?
RCCA operates as a physician-led network of community oncology practices. Specific financial ownership details, including any single-family office or private equity backing, have not been publicly disclosed. The model emphasizes independent physician governance.
Is RCCA part of a larger healthcare system or hospital network?
No, RCCA stands apart from large hospital systems. It is structured as a community oncology network, allowing patients to receive advanced treatment and clinical research in lower-cost suburban settings rather than academic medical centers.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: